Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05787782 · ClinicalTrials.gov registry record · NA
Validation of the Masimo INVSENSOR00063 in Febrile and Afebrile Subejcts
A NA study, sponsored by Masimo Corporation.
- Completed
- Registry status
- NA
- Development phase
- 60
- Enrollment target
NCT05787782: Completed NA study, sponsored by Masimo Corporation.
NCT05787782 is a NA study that has completed, run by Masimo Corporation. The registered enrollment target is 60 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05787782, a NA study, has completed, sponsored by Masimo Corporation.
- COMPLETED
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
Study Summary
This is a prospective, non-randomized data collection study to evaluate the performance of the Masimo INVSENSOR00063 in obtaining temperature measurements.
Primary Outcome
Masimo INVSENSOR00063 temperature measurements will be compared to reference temperature measurements. Accuracy of Masimo INVSENSOR00063 will be measured using clinical bias, limits of agreement and repeatability.
Interventions
- DEVICE Masimo INVSENSOR00063
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2023-02-23 |
| Est. Completion | 2023-03-02 |
| Phase | NA |
What the finished NCT05787782 record still lists
NCT05787782 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 60 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).
The record links to 0 conditions, and to 1 intervention - of which Masimo INVSENSOR00063 is the first listed.
NCT05787782 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05787782 about?
NCT05787782 is a clinical study titled "Validation of the Masimo INVSENSOR00063 in Febrile and Afebrile Subejcts". This is a prospective, non-randomized data collection study to evaluate the performance of the Masimo INVSENSOR00063 in obtaining temperature measurements.
What is the current status of trial NCT05787782?
This trial is currently completed. It is a NA study. The enrollment target is 60 participants. The study started on 2023-02-23. Estimated completion is 2023-03-02.
What interventions are being tested in trial NCT05787782?
The interventions under investigation include: Masimo INVSENSOR00063 (DEVICE).
Who is sponsoring clinical trial NCT05787782?
This trial is sponsored by Masimo Corporation, which has 96 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05787782's enrollment target sits among peer trials
60 1164th of 2000 higher than 745 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00576069 · 60 participants
Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma
- NCT01297400 · 60 participants · Phase 2
Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns
- NCT01734122 · 60 participants
Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor
- NCT01804634 · 60 participants · Phase 2
Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI